Novo Holdings' antibiotic resistance fund backs 3 biotechs

Novo Holdings’ REPAIR Impact Fund has revealed investments in three antibiotic resistance startups. The investments funneled around $16 million (€14 million) of the fund’s $165 million budget into the startups to support research into antibiotics and prophylactic vaccines.